Assessing pre-transplant flow cytometry measurable residual disease in pediatric AML patients undergoing allogeneic stem cell transplant and its prognostic significance.
Key Takeaways
- Acute myeloid leukemia (AML) is one of the most common malignancies in children ( 1 , 2 )
- Although the prognosis of pediatric AML has significantly improved due to optimized chemotherapy
- Multiple studies have confirmed that measurable residual disease (MRD)